If you have hypermobile Ehlers-Danlos Syndrome (hEDS) or hypermobility spectrum disorder (HSD) and you're reading this because your gut has been a disaster for years -- you're not imagining it, and it's not just anxiety. Studies show that GI symptoms affect 75% or more of hEDS patients, and the prevalence of SIBO in this population is dramatically higher than in the general public. The connection isn't mysterious: the same connective tissue that makes your joints bendy also makes your gut walls lax, your blood vessels stretchy (hello dysautonomia), your mast cells unstable, and your autonomic nervous system unreliable. All of these feed directly into SIBO risk. The frustrating part is that most gastroenterologists don't think about connective tissue, and most geneticists don't think about gut bacteria. This guide bridges the gap.
How hEDS Leads to SIBO
The gut is a muscular tube surrounded by connective tissue. In hEDS, the collagen that forms the structural scaffold of the gut wall is abnormally lax. This affects every layer -- the mucosal lining, the muscularis (the muscle layers that contract for peristalsis), and the serosa (the outer layer). Lax muscularis means weaker contractions, which translates directly to impaired motility and a weak migrating motor complex. Lax connective tissue also allows organs to shift position -- gastroptosis (stomach dropping), visceroptosis (intestinal sagging), and increased ileocecal valve incompetence are all more common in hEDS. When the ileocecal valve doesn't close properly, colonic bacteria migrate backward into the small intestine.
Beyond the gut itself, hEDS drives SIBO through several systemic mechanisms. Dysautonomia (particularly POTS -- postural orthostatic tachycardia syndrome) affects the vagus nerve's ability to regulate digestive function. Blood pooling in the splanchnic circulation after meals diverts blood from other areas and alters the normal postprandial digestive response. Mast cell activation, which is overrepresented in hEDS, dumps histamine and inflammatory mediators into the gut lining. And the chronic pain that comes with hEDS often leads to opioid use, which is one of the strongest suppressors of gut motility known.
The hEDS-MCAS-Dysautonomia Triad
hEDS patients rarely have just hEDS. The cluster of hEDS plus mast cell activation syndrome (MCAS) plus dysautonomia (usually POTS) is so common that researchers have begun studying it as a unified entity. Each condition worsens the others: connective tissue laxity makes mast cells more fragile and easier to degranulate, mast cell mediators cause vasodilation that worsens POTS, and dysautonomia impairs vagal regulation of the gut. For SIBO treatment, this means you often can't successfully treat the bacterial overgrowth without also stabilizing mast cells and managing autonomic dysfunction -- otherwise the underlying conditions immediately re-create the environment for relapse.
Why Standard SIBO Treatment Fails in hEDS
Reasons hEDS patients struggle with SIBO treatment:
- Impaired motility is structural, not just functional -- prokinetics help but can't fully overcome lax gut walls
- Ileocecal valve incompetence allows continuous bacterial re-seeding from the colon
- Mast cell reactivity causes food intolerances that make dietary interventions harder
- Dysautonomia impairs vagal tone, reducing the natural digestive cascade
- Chronic pain management may involve opioids that worsen motility
- Multiple medication sensitivities make finding tolerable antimicrobials difficult
- Gastroparesis (delayed gastric emptying) often coexists, adding another layer
- The restrictive diets used for SIBO can worsen nutritional deficiencies already present from malabsorption
Treatment Approach for hEDS + SIBO
Treating SIBO in hEDS requires addressing the system, not just the bacteria. Step one: stabilize the autonomic nervous system and mast cells before or during antimicrobial treatment. This means managing POTS with adequate hydration (aim for 2-3 liters daily), electrolytes, compression garments, and possibly medications like fludrocortisone or midodrine. It means stabilizing mast cells with H1 and H2 antihistamines, cromolyn sodium, and quercetin. And it means supporting vagal tone with breathing exercises, as vagal dysfunction is particularly common in hEDS.
Step two: treat the SIBO itself, but with expectations calibrated to hEDS. Full eradication may not be realistic if the structural motility defect is severe. Instead, the goal is to reduce the overgrowth enough to control symptoms and prevent progression. Lower antimicrobial doses may be needed if medication sensitivity is an issue. Herbal antimicrobials are often better tolerated than pharmaceuticals in this population. Step three: long-term prokinetic use is not optional -- it's essential. Prucalopride is the preferred prokinetic because it has the strongest motility effect. Many hEDS patients need lifelong prokinetic support. Step four: address the ileocecal valve. Some practitioners use ileocecal valve massage techniques to improve closure, and some patients benefit from targeted visceral manipulation of the ICV area.
Dietary Considerations for hEDS + SIBO
Diet for hEDS plus SIBO is a balancing act. Standard SIBO diets (low FODMAP, specific carbohydrate, bi-phasic) can be helpful for symptom control but are nutritionally restrictive, and hEDS patients already have higher nutritional demands due to impaired collagen synthesis and malabsorption. Strict elimination diets can lead to dangerous weight loss, nutritional deficiencies, and disordered eating patterns in a population already prone to all three. A moderate approach -- reducing the most offensive FODMAP triggers while maintaining broad nutritional coverage -- is usually better than strict elimination. Work with a dietitian experienced in both hEDS and GI nutrition if possible. Liquid meals (smoothies, soups, bone broth) are often better tolerated than solid meals because they require less mechanical digestive effort.
Gastroparesis: The Common Comorbidity
Delayed gastric emptying affects a significant portion of hEDS patients and directly contributes to SIBO. When food sits in the stomach too long, it ferments before reaching the small intestine, and the delayed emptying pattern disrupts the normal MMC cycling. Treatment includes the same prokinetics used for SIBO (prucalopride works on gastric emptying too), smaller and more frequent meals, avoiding lying down after eating, and dietary modifications to reduce fat and fiber (both slow emptying). A gastric emptying study (scintigraphy) can confirm the diagnosis if suspected.
Managing Expectations
This is the part nobody wants to hear: hEDS is a genetic structural condition, and the gut laxity that comes with it is permanent. You can't cure the connective tissue problem, so the goal shifts from 'eradicate SIBO and move on' to 'manage SIBO as a chronic condition with sustainable long-term strategies.' Many hEDS patients with well-managed SIBO still experience GI symptoms -- some of those symptoms come from the motility disorder itself, not from active bacterial overgrowth. Learning to distinguish between 'SIBO is back' and 'this is baseline hEDS gut' is important for avoiding unnecessary antimicrobial cycles. Tracking symptoms and correlating with breath test results in GLP1Gut helps identify this threshold.
âšī¸If you suspect hEDS, the diagnostic criteria require evaluation by a geneticist or rheumatologist familiar with the 2017 diagnostic criteria. Beighton score alone is not sufficient for diagnosis. Many hEDS patients go undiagnosed for years because their symptoms are attributed to anxiety or hypochondria.
Why is SIBO so common in hEDS patients?
The connective tissue laxity in hEDS directly impairs gut motility by weakening the muscular walls that propel food forward. It also causes ileocecal valve incompetence (allowing colonic bacteria to migrate backward into the small intestine), contributes to gastroparesis, and is associated with dysautonomia that impairs vagal regulation of digestion. Add mast cell activation (overrepresented in hEDS) that increases gut inflammation, and you have a perfect setup for recurrent SIBO. Studies show GI symptoms affect 75%+ of hEDS patients, and SIBO prevalence is dramatically higher than in the general population.
Can SIBO be cured in hEDS patients?
Honest answer: probably not permanently, because the underlying structural issue (connective tissue laxity) that predisposes to SIBO is genetic and permanent. The realistic goal is long-term management -- keeping bacterial overgrowth controlled with prokinetics, periodic antimicrobial courses when needed, dietary strategies, and addressing comorbidities like MCAS and dysautonomia. Many hEDS patients achieve good symptom control with this approach, even if they need maintenance treatment indefinitely. The shift from 'cure' to 'manage' is important for mental health -- endless cycles of treatment-hope-relapse-despair are worse than accepting a chronic management model.
What is the best prokinetic for hEDS patients with SIBO?
Prucalopride (Motegrity) is generally the first choice because it has the strongest direct effect on the migrating motor complex and works on both the small intestine and colon. Many hEDS patients need lifelong prokinetic support at 1-2mg nightly. Low-dose erythromycin (50mg) is a cheaper alternative but loses effectiveness after 4-6 weeks due to receptor desensitization. Some practitioners combine pharmaceutical and natural prokinetics for maximum coverage. For hEDS patients with POTS, adequate hydration and electrolytes are prerequisite for prokinetics to work -- dehydration impairs gut motility independently.
Should I treat MCAS, POTS, or SIBO first in hEDS?
Ideally all three simultaneously, but if you have to prioritize: stabilize POTS first (hydration, electrolytes, compression, medications), then address MCAS (antihistamines, mast cell stabilizers), then treat SIBO. The reasoning: POTS impairs gut blood flow and vagal function, and MCAS creates gut inflammation -- both actively undermine SIBO treatment. Stabilizing these conditions first means SIBO treatment is more likely to work. In practice, many hEDS patients start antihistamines, increase hydration, and begin SIBO treatment within the same timeframe rather than strict sequential ordering.
What diet is best for hEDS with SIBO?
A moderate approach is better than strict elimination in hEDS because nutritional demands are high and restrictive diets risk dangerous deficiencies and weight loss in an already vulnerable population. Reduce the most offensive FODMAP triggers while maintaining broad nutritional coverage. Liquid meals (smoothies, soups, bone broth) are often better tolerated than solid meals. Work with a dietitian experienced in both hEDS and GI nutrition if possible. Avoid strict long-term elimination diets -- they create more problems than they solve in hEDS patients who are already prone to malabsorption and malnutrition.
âšī¸Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. hEDS, MCAS, and dysautonomia require diagnosis and management by qualified specialists. Always work with a healthcare team familiar with these conditions.